How isn't it measured against SoC when the patients need to have failed multiple current treatments to be on the clinical trial with the safety and efficacy comparison available??? So they aren't done in combination with current SoC which make these assets commercial viable as the drug will be SoC after regulatory approval and not used in combination with current SoC.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)